Page last updated: 2024-09-02

tadalafil and Angiogenesis, Pathologic

tadalafil has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jansson, PA; Lönnroth, P; Murdolo, G; Sjöstrand, M; Strindberg, L	1

Trials

1 trial(s) available for tadalafil and Angiogenesis, Pathologic

Article	Year
The selective phosphodiesterase-5 inhibitor tadalafil induces microvascular and metabolic effects in type 2 diabetic postmenopausal females. The Journal of clinical endocrinology and metabolism, 2013, Volume: 98, Issue:1 Topics: Adipose Tissue; Body Composition; Carbolines; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Microdialysis; Microvessels; Middle Aged; Muscle, Skeletal; Neovascularization, Pathologic; Phosphodiesterase 5 Inhibitors; Postmenopause; Substrate Specificity; Tadalafil	2013

Article

Year

The selective phosphodiesterase-5 inhibitor tadalafil induces microvascular and metabolic effects in type 2 diabetic postmenopausal females.

The Journal of clinical endocrinology and metabolism, 2013, Volume: 98, Issue:1

Topics: Adipose Tissue; Body Composition; Carbolines; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Microdialysis; Microvessels; Middle Aged; Muscle, Skeletal; Neovascularization, Pathologic; Phosphodiesterase 5 Inhibitors; Postmenopause; Substrate Specificity; Tadalafil

2013